Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Wunderlich

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Pulmonary Pharmacology & Therapeutics|January 30, 2008
Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout miceCarsten Wunderlich, Alexander Schmeisser, Christian Heerwagen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2017
A novel interventional method for treating femoral pseudoaneurysms: results from a monocentric experienceKarim Ibrahim, Marian Christoph, Carsten Wunderlich, et al.
Acta Cardiologica|October 13, 2015
Target temperature management of 33 degrees C exerts beneficial haemodynamic effects after out-of-hospital cardiac arrestMathias Forkmann, Steffen Kolschmann, Luise Holzhauser, et al.
Molecular and Cellular Biochemistry|October 16, 2012
Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarctionBernd Ebner, Stefan A Lange, Thomas Eckert, et al.
The Canadian Journal of Cardiology|November 28, 2017
Endothelial Nitric Oxide Synthase-Induced Hypertrophy and Vascular Dysfunction Contribute to the Left Ventricular Dysfunction in Caveolin-1<sup>-/-</sup> MiceAnnette Ebner, Nadine Kuerbis, Aljoscha Brandt, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout miceCarsten Wunderlich, Kristin Schober, Michael Kasper, et al.
Journal of Cardiovascular Pharmacology|March 12, 2013
Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted miceAnne-Katrin Polanski, Annette Ebner, Bernd Ebner, et al.
Journal of Molecular and Cellular Cardiology|April 18, 2008
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endotheliumCarsten Wunderlich, Kristin Schober, Alexander Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2015
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillationChristian Pfluecke, Daniel Tarnowski, Lina Plichta, et al.
Atherosclerosis|February 25, 2014
Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- miceMarian Christoph, Karim Ibrahim, Kathleen Hesse, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Pulmonary Pharmacology & Therapeutics|January 30, 2008
Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout miceCarsten Wunderlich, Alexander Schmeisser, Christian Heerwagen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2017
A novel interventional method for treating femoral pseudoaneurysms: results from a monocentric experienceKarim Ibrahim, Marian Christoph, Carsten Wunderlich, et al.
Acta Cardiologica|October 13, 2015
Target temperature management of 33 degrees C exerts beneficial haemodynamic effects after out-of-hospital cardiac arrestMathias Forkmann, Steffen Kolschmann, Luise Holzhauser, et al.
Molecular and Cellular Biochemistry|October 16, 2012
Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarctionBernd Ebner, Stefan A Lange, Thomas Eckert, et al.
The Canadian Journal of Cardiology|November 28, 2017
Endothelial Nitric Oxide Synthase-Induced Hypertrophy and Vascular Dysfunction Contribute to the Left Ventricular Dysfunction in Caveolin-1<sup>-/-</sup> MiceAnnette Ebner, Nadine Kuerbis, Aljoscha Brandt, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout miceCarsten Wunderlich, Kristin Schober, Michael Kasper, et al.
Journal of Cardiovascular Pharmacology|March 12, 2013
Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted miceAnne-Katrin Polanski, Annette Ebner, Bernd Ebner, et al.
Journal of Molecular and Cellular Cardiology|April 18, 2008
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endotheliumCarsten Wunderlich, Kristin Schober, Alexander Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2015
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillationChristian Pfluecke, Daniel Tarnowski, Lina Plichta, et al.
Atherosclerosis|February 25, 2014
Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- miceMarian Christoph, Karim Ibrahim, Kathleen Hesse, et al.
Pageof 6